Physician profile

Antony G Kaliyadan

Interventional Cardiology · Baltimore, MD

NPI 1275741662

$6,774.64

in general payments reported to CMS, 2019-2025

15 companies · $576 in 2025

The $576 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

See the full distribution for Interventional Cardiology

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$2,203.87
Travel and Lodging$1,815.30

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Edwards Lifesciences Corporation $2,886.13 2019-2025 Evoque
Boston Scientific Corporation $1,521.33 2019-2025 Synergy, Opticross
Abbott Laboratories $1,209.12 2019-2025 Amplatzer Amulet, Navitor
Medtronic, INC. $685.96 2021-2025 Onyx Frontier, Corevalve Evolut R, Azure Xt Dr Mri Surescan
Inari Medical, INC. $110.95 2022-2024 Ct Thrombectomy System Kit, Flowtriever Catheter, S
Philips North America LLC $89.60 2023-2025 Fm Other, (9266) Elca
Stryker Corporation $64.04 2025 Flowtriever Catheter, S, Ct Thrombectomy System Kit, Flowtriever
Biotronik INC. $57.24 2019-2021
Shockwave Medical, INC $38.73 2019-2022
Teleflex LLC $27.65 2024 Guideliner
Abiomed $23.53 2021
Astrazeneca Pharmaceuticals LP $19.16 2019
Terumo Medical Corporation $16.20 2024 Metacross Otw, Angio-Seal, Glidewire
Zoll Services LLC (A/K/A Zoll Lifecor Corp) $13.33 2022
Cardinal Health 200 LLC $11.67 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Antony G Kaliyadan

$6,774.64

in general payments reported 2019-2025

Years
2019-2025
Top company
Edwards Lifesciences Corporation
Context
The $576 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).

https://glasscript.com/doctor/193539/antony-g-kaliyadan

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.